Respimat®

At Boehringer Ingelheim, we provide innovative treatments for Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF) and Asthma.

Respimat® requires no special inhalation effort. It delivers medication actively with the unique mist:

  • Slow-moving: The slow velocity of the mist helps the medication pass the natural curve of the throat
  • Long-lasting: Time for your patients to naturally breathe in the medication
  • Fine droplets: Helps your patients to get the medication deep into their lungs
Information for...
General Use Patients or Carers Health Care Professionals in the US Health Care Professionals outside the US Journalists Jobseekers

Disclaimer

We recognise that the Internet serves a global community. The pharmaceutical industry, however, is subject to country specific regulatory considerations, which affect the information we can provide on our products. In addition, the registration status of pharmaceutical products may not be the same in different regions of the world and the approved product labels may also differ according to country specific requirements.
Therefore, please check the registration details of this/these product(s) locally in order to get up-to-date information.